RVX-297
CAS No. 1044871-04-6
RVX-297 ( RVX297 )
Catalog No. M10223 CAS No. 1044871-04-6
RVX-297 is a novel orally active, BD2 selective, BET bromodomain inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 177 | Get Quote |
|
10MG | 295 | Get Quote |
|
25MG | 502 | Get Quote |
|
50MG | 709 | Get Quote |
|
100MG | 1008 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRVX-297
-
NoteResearch use only, not for human use.
-
Brief DescriptionRVX-297 is a novel orally active, BD2 selective, BET bromodomain inhibitor.
-
DescriptionRVX-297 is a novel orally active, BD2 selective, BET bromodomain inhibitor with Alpha Screen IC50 of 0.08, 0.05 and 0.02 uM for BRD2 (BD2), BRD3 (BD2) and BRD4 (BD2), respectively; displays about 50-fold selectivity over BD1; suppresses inflammatory gene expression in multiple immune cell types in culture; reduces pro-inflammatory mediators assessed in splenic gene expression and serum proteins in LPS model of inflammation.
-
SynonymsRVX297
-
PathwayChromatin/Epigenetic
-
TargetBromodomain
-
RecptorBromodomain
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1044871-04-6
-
Formula Weight423.51
-
Molecular FormulaC24H29N3O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOC1=C(C(NC(C2=CC(C)=C(OCCN3CCCC3)C(C)=C2)=N4)=O)C4=CC(OC)=C1
-
Chemical Name2-(3,5-dimethyl-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kharenko OA, et al. Biochem Biophys Res Commun. 2016 Aug 12;477(1):62-7.
molnova catalog
related products
-
TPOP146
A potent and selective CBP/p300 bromodomain inhibitor with Kd of 134 nM for CBP bromodomain.
-
GSK4027
GSK4027 (GSK 4027, GSK-4027) is a potent, selective, cell-penetrant chemical probe of PCAF/GCN5 bromodomain with pKi of 8.9 for both.
-
BRD4 inhibitor Compo...
BRD4 inhibitor Compound V is a domain-selective inhibitor of BRD4 with IC50 of 1.8 uM for BRD4 BD1, displays 6- and 16-fold selectivity for BRD4 over BRD2 and BRD3, respectively.